Vernalis Stock Price (OTCMKTS:VNLPY)

Add to My Stocks
$0.38 $0 (0%) VNLPY stock closing price Sep 20, 2018 (Closing)
Prev Close* : $0.38
Market Cap:
$100.62M
Day Low: $0
52 Week Low: $0.05
Open: $0
Volume: $0
Day High: $0
52 Week High: $0.56
Dividend:
0.00

Latest Stock Market News

Latest Articles

VNLPY Stockcharts

View VNLPY PE ratio, PS ratio stocks charts and compare with peers.
VNLPY Chart
Note: Compare Vernalis stock price history with the index and industry peers.

Vernalis Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Vernalis Returns

ROE
(return on equity)

Vernalis Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

VNLPY Industry Peers

Company Price Change (%)
Oasmia Pharma (OASM)2.750.3 (9.84%)
Processa Pharma (PCSA)3.950.65 (19.7%)
Champions Oncology (CSBR)13.981.68 (13.66%)
Biotie Therapies (BITI)25.80.71 (2.68%)
Astrazeneca (AZN)37.30.19 (0.51%)
Astrazeneca (AZN)37.30.19 (0.51%)
Glaxosmithkline (GSK)39.550.08 (0.2%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

Vernalis Financial Statements

income statement20172016201320122011
Net Sales or Revenues26.36M17.85M22.04M23.16M19.5M
Net Income-27.34M-21.5M-6.26M-8.31M-12.31M
Total Operating Expense56.72M49.86M27.43M28.88M33.49M
View Vernalis income statement
balance sheet20172016201420132012
Total Assets119.43M166.92M145.9M152.08M154.24M
Total Liabilities14.44M14.48M14.55M13.83M16.28M
Shareholders Equity104.98M152.44M131.35M138.25M137.95M
View Vernalis balance sheet
cash flow statement20172016
Net Increase (Decrease) in Assets Liabilities3.52M3.53M
Net Cash from (used by) Operating Activities-25.8M-30.82M
Increase (Decrease) in Prop Plant And Equipment-0.54M-0.31M
View Vernalis cash flow statement

Vernalis Stock Message Board

Vernalis stock price ended the last trading day at $0.38. Stock price or share price can be used to find the total market value of a company. Vernalis market cap stands at $100.62M as of Sep 20, 2018. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Vernalis stock analysis.

The terms stocks and shares mean the same thing. For Ex: Vernalis stock price and Vernalis share price mean the same thing. The volume number in Vernalis stock quote data shows the number of shares traded. For Ex: 0 Vernalis shares were traded as of last trading day, as seen from Vernalis stock chart. Vernalis paid 0.00 stock dividends to its shareholders during last quarter. One can observe stock price trends and check for volatility by checking Vernalis stock price history.